Medpace Holdings revenue and financials
$607.25Change from previous close: −2.14%Absolute change: −$13.26
In the fiscal year ended December 2025, Medpace Holdings reported revenue of $2.53B (+19.97% year over year). Net income was $451.12M, a net margin of 17.8%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +19.97%
- 2025 vs 2024
- Net income growth
- +11.56%
- 2025 vs 2024
- Net margin
- 17.8%
- 2024: 19.2%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2,530 | 2,109 | 1,886 | 1,460 | 1,142 | 926 | 861 | 705 | 436 | 422 |
| Cost of revenue | 732 | 682 | 638 | 535 | 441 | — | — | — | — | — |
| Gross profit | 1,798 | 1,427 | 1,248 | 925 | 701 | — | — | — | — | — |
| Selling, general and administrative | 198 | 180 | 161 | 131 | 108 | — | — | — | — | — |
| Operating income | 535 | 447 | 337 | 279 | 199 | 167 | 127 | 101 | 64.9 | 52.5 |
| EBIT | 535 | 447 | 337 | 279 | 199 | — | — | — | — | — |
| EBITDA | 563 | 476 | 363 | 301 | 220 | — | — | — | — | — |
| Interest expense | — | — | 0.5 | 2.9 | 0.1 | — | — | — | — | — |
| Pre-tax income | 542 | 476 | 336 | 283 | 202 | — | — | — | — | — |
| Income tax | 91.3 | 71.5 | 52.9 | 37.5 | 20.0 | 23.1 | 24.4 | 20.8 | 17.8 | 8.5 |
| Net income | 451 | 404 | 283 | 245 | 182 | 145 | 100 | 73.2 | 39.1 | 13.4 |
| Net income to common shareholders | 451 | 404 | 283 | 245 | 181 | — | — | — | — | — |
| Basic EPS | 15.64 | 13.06 | 9.20 | 7.57 | 5.06 | 4.07 | 2.79 | 2.05 | 1.00 | 0.38 |
| Diluted EPS | 15.28 | 12.63 | 8.88 | 7.28 | 4.81 | 3.84 | 2.67 | 1.97 | 0.98 | 0.37 |
| Average shares (basic) | 28.8 | 31.0 | 30.7 | 32.4 | 35.9 | — | — | — | — | — |
| Average shares (diluted) | 29.5 | 32.0 | 31.8 | 33.7 | 37.7 | 37.7 | 37.6 | 36.9 | 39.8 | 36.3 |